Age, COVID-19-like symptoms and SARS-CoV-2 seropositivity profiles after the first wave of the pandemic in France

Analytical evaluation and critical appraisal of early commercial SARS-CoV-2 immunoassays for routine use in a diagnostic laboratory.

(2021) A Cramer et al.   BRITISH JOURNAL OF BIOMEDICAL SCIENCE

Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study

(2021) Zhenyu He et al.   LANCET

Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study

(2021) Fabrice Carrat et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis

(2021) Niklas Bobrovitz et al.   PLoS One

Longitudinal dynamics of the neutralizing antibody response to SARS-CoV-2 infection

(2020) Kai Wang et al.   CLINICAL INFECTIOUS DISEASES

Distinct Early Serological Signatures Track with SARS-CoV-2 Survival

(2020) Caroline Atyeo et al.   IMMUNITY

Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors

(2020) Pierre Gallian et al.   ANTIVIRAL RESEARCH

Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China

(2020) Fan Wu et al.   JAMA Internal Medicine

Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults

(2020) Russell M. Viner et al.   JAMA Pediatrics

Validation of dried blood spot sample modifications to two commercially available COVID-19 IgG antibody immunoassays

(2020) Theodore T Zava et al.   Bioanalysis